Forward Citations = 59

Loading Chart...

4 inventors (with patents filed for the assignee):

Lee D Arnold (7 out of 17 patents)

Walter Keung (7 out of 7 patents)

Andy Jennings (6 out of 7 patents)

4. Uri Lopatin (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12747230 - Inhibitors of cysteine proteases and methods of use thereof (2026-09-29),

2. 12145911 - Inhibitors of cysteine proteases and methods of use thereof (2024-11-19),

3. 11524940 - Inhibitors of cysteine proteases and methods of use thereof (2022-12-13),

4. 11472793 - Inhibitors of cysteine proteases and methods of use thereof (2022-10-18),

5. 11312704 - Inhibitors of cysteine proteases and methods of use thereof (2022-04-26),

6. 11174231 - Inhibitors of cysteine proteases and methods of use thereof (2021-11-16),

7. 11124497 - Inhibitors of cysteine proteases and methods of use thereof (2021-09-21),

Company Overview

Pardes Biosciences, Inc. is a leading biotechnology company dedicated to developing innovative solutions for a range of healthcare challenges. With a focus on research and development, Pardes Biosciences is committed to improving lives through cutting-edge biological discoveries.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#142 in Carlsbad, CA

#9,501 in California

#39,907 in US

Carlsbad, CA, United States of America

Pardes Biosciences, Inc.

Forward Citations = 59

4 inventors:

Lee D Arnold (7 out of 17 patents)

Walter Keung (7 out of 7 patents)

Andy Jennings (6 out of 7 patents)

4. Uri Lopatin (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pardes Biosciences, Inc.. Retrieved from https://idiyas.com/company/pardes-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]